Pretreatment plasma TGFb1 levels are prognostic for survival but not morbidity following radiation therapy of carcinoma of the cervixCitation formats

  • Authors:
  • J Dickson
  • SE Davidson
  • RD Hunter
  • CML. West

Standard

Pretreatment plasma TGFb1 levels are prognostic for survival but not morbidity following radiation therapy of carcinoma of the cervix. / Dickson, J; Davidson, SE; Hunter, RD; West, CML.

In: International Journal of Radiation Oncology Biology Physics, Vol. 48, 2000, p. 991-995.

Research output: Contribution to journalArticlepeer-review

Harvard

Dickson, J, Davidson, SE, Hunter, RD & West, CML 2000, 'Pretreatment plasma TGFb1 levels are prognostic for survival but not morbidity following radiation therapy of carcinoma of the cervix', International Journal of Radiation Oncology Biology Physics, vol. 48, pp. 991-995.

APA

Dickson, J., Davidson, SE., Hunter, RD., & West, CML. (2000). Pretreatment plasma TGFb1 levels are prognostic for survival but not morbidity following radiation therapy of carcinoma of the cervix. International Journal of Radiation Oncology Biology Physics, 48, 991-995.

Vancouver

Dickson J, Davidson SE, Hunter RD, West CML. Pretreatment plasma TGFb1 levels are prognostic for survival but not morbidity following radiation therapy of carcinoma of the cervix. International Journal of Radiation Oncology Biology Physics. 2000;48:991-995.

Author

Dickson, J ; Davidson, SE ; Hunter, RD ; West, CML. / Pretreatment plasma TGFb1 levels are prognostic for survival but not morbidity following radiation therapy of carcinoma of the cervix. In: International Journal of Radiation Oncology Biology Physics. 2000 ; Vol. 48. pp. 991-995.

Bibtex

@article{5da3ef1217e84410a7be96c73686beaf,
title = "Pretreatment plasma TGFb1 levels are prognostic for survival but not morbidity following radiation therapy of carcinoma of the cervix",
author = "J Dickson and SE Davidson and RD Hunter and CML. West",
year = "2000",
language = "English",
volume = "48",
pages = "991--995",
journal = "International Journal of Radiation: Oncology - Biology - Physics",
issn = "0360-3016",
publisher = "Elsevier BV",

}

RIS

TY - JOUR

T1 - Pretreatment plasma TGFb1 levels are prognostic for survival but not morbidity following radiation therapy of carcinoma of the cervix

AU - Dickson, J

AU - Davidson, SE

AU - Hunter, RD

AU - West, CML.

PY - 2000

Y1 - 2000

M3 - Article

VL - 48

SP - 991

EP - 995

JO - International Journal of Radiation: Oncology - Biology - Physics

JF - International Journal of Radiation: Oncology - Biology - Physics

SN - 0360-3016

ER -